Nanoemulsions and Microemulsions for Intranasal Drug Delivery: A Bibliometric Analysis and Emerging Trends (2004–2024)
Pharmaceutics · 25.08.2025 · 17 (9) · 1104
DOI: 10.3390/pharmaceutics17091104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 25.08.2025. Verfasst von Ariane Krause Padilha Lorenzett und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia St., 838, Guarapuava 85040-167, …. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) -Brazil, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES - Brazil), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
Background/Objectives: Nanoemulsions and microemulsions are promising drug delivery systems capable of enhancing the solubility, stability, and bioavailability of active pharmaceutical ingredients, particularly for central nervous system (CNS) disorders. This study presents a bibliometric analysis of scientific publications on intranasal nanoemulsions from 2004 to 2024, based on data from the Scopus database.
Methods
A total of 379 articles were analyzed using Bibliometrix and VOSviewer to identify publication trends, leading countries and institutions, prominent journals, and keyword networks.
Results
Publications grew significantly over the last decade, with India, the United States, and China leading in volume. Keyword analysis revealed strong thematic clusters related to “brain targeting,” “drug delivery,” and “intranasal administration,” highlighting this route’s potential for bypassing the blood–brain barrier. The most studied compounds included curcumin, quercetin, carbamazepine, diazepam, and insulin, each with therapeutic applications in neurodegenerative and psychiatric disorders.
Conclusions
The findings highlight growing interest in intranasal nano- and microemulsions as a non-invasive and efficient CNS delivery strategy. Future research can bridge translational gaps, enhancing efficacy and safety while meeting regulatory expectations for patient-centered drug development. This study provides a comprehensive overview of current trends and serves as a guide for advancing innovative intranasal delivery platforms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Nanostructured Formulations, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia St., 838, Guarapuava 85040-167, PR, Brazil.
- Chemistry Department, Federal Technological University of Paraná UTFPR, Via do Conhecimento, s/n, KM 01, Fraron, Pato Branco 85503-390, PR, Brazil.
- Department of Neurological Surgery, Federal Hospital of Ipanema, Rio de Janeiro 22411-020, RJ, Brazil.
ORCID-Profile: Ariane Krause Padilha Lorenzett
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) -Brazil
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES - Brazil)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Zitieren
APA
Lorenzett, A. K. P., Lima, V. A., Fonseca, C. O. P. D., & Mainardes, R. M. (2025). Nanoemulsions and Microemulsions for Intranasal Drug Delivery: A Bibliometric Analysis and Emerging Trends (2004–2024). Pharmaceutics, 17(9), 1104. https://doi.org/10.3390/pharmaceutics17091104
Vancouver
Lorenzett AKP, Lima VA, Fonseca COPD, Mainardes RM. Nanoemulsions and Microemulsions for Intranasal Drug Delivery: A Bibliometric Analysis and Emerging Trends (2004–2024). Pharmaceutics. 2025;17(9):1104. doi:10.3390/pharmaceutics17091104
BibTeX
@article{Lorenzett2025,
author = {Lorenzett, Ariane Krause Padilha and Lima, Vanderlei Aparecido de and Fonseca, Clovis Orlando Pereira da and Mainardes, Rubiana Mara},
title = {Nanoemulsions and Microemulsions for Intranasal Drug Delivery: A Bibliometric Analysis and Emerging Trends (2004–2024)},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {9},
pages = {1104},
doi = {10.3390/pharmaceutics17091104}
}
EUVIMED